통합검색

교수진

김경순 프로필 사진
  • 성명

    김경순 교수

  • 전공

    약품분석화학

  • 최종학위

    서울대학교 약학박사

  • 연구실

    PRIME의생명공학관(J동) 412호

  • 연락처

    055-320-4039

  • 이메일

    kskim@inje.ac.kr

교육 및 연구경력

  • B.S., College of Pharmacy, Ewha Womens University
  • M.S., Pharmaceutical Analytical Chemistry, Seoul National University 
  • Ph.D., Pharmaceutical Analytical Chemistry, Seoul National University 
  • Research scientist/ MOGAM Biotech. Institute, Greencross Co./Immune team
  • Research Professor/ College of Pharmacy, Chung-Buk National University
  • 임상 CRA 청년취업아카데미 강사 (바이오협회)
  • 의료기기 임상시험 의뢰자과정 강사 (보건산업진흥원)
  • 의료기기 임상시험 전문가 심화과정 강사 (의료기기산업협회)

기타 및 학술관련 경력

  • CRA 직무분석 연구회 (바이오협회)
  • 의료기기 임상시험 의뢰자 표준교육교재개발 워킹 그룹 (보건산업진흥원)
  • 의료기기산업협회 CHAMP 사업 교육분과위원회 전문위원

연구 관심 분야

  • Clinical study developing and management 
  • Regulatory affairs for new drug development 
  • Clinical pharmacology
  • Drug environmental monitoring

강의 분야

  • 신약개발
  • 임상관리학
  • 약품분석학
  • 법분석화학
  • 의약품제조과학
  • 의약품품질관리학

저서 및 주요 논문

논문

  • Orally disintegration films focusing on formulation manufacturing process, and charaterization, Yeongbin Lee, Kyeongsoon Kim, Minsoo Kim, Du Hyung Choi, Seong Hoon Jeong, Journal of Pharmaceutical Investigation (2017) 47:183-201 
  • Catalytic reduction of 4-nitrophenol with gold nanoparticles synthesized by caffeic acid, Yu Seon Seo, Eun-Young Ahn, Jisu Park, Jee Eun Hong, Kyeongsoon Kim, Yohan Park and Youmie Park, Nanoscale Research Letters (2017) 12:7
  • Improved dissolution and oral bioavailability of celecoxib by a dry elixir system, Kwan Hyung Cho, Jun-Pil Jee, Da A Yang, Sung Tae Kim, Dongjin Kang, Dae-Young Kim, Taeyong Sim, Sang Yeob Park, Kyeongsoon Kim, and Dong-Jin Jang, Journal of Nanoscience and Nanotechnology (2018) 18(2) 1482-1486
  • Removing control of cyclodextrin-drug complexes using high affinity moleculeYong Hwan Kim, Sung Tae Kim, Jun-Pil Jee, Dae-Young Kim, Dongjin Kang, Kyeongsoon Kim, Sang Yeob Park, Taeyong Sim, Kwan Hyung Cho and Dong-Jin Jang, Journal of Nanoscience and Nanotechnology (2018) 18(2) 898-901
  • Mosquito insecticidal activities of naturally occuring coompounds derived from Piper species, In Kyung Bae and Kyeongsoon Kim, Sung-Deuk Choi, Kyu-Sik Chang, Hoi-Seon Lee, Sung-Een Lee, Appl Biol Chem (2017) 60(2): 113-117
  • Monitoring and risk assessment of polychlorinated biphenyls (PCBs) in agricultural soil from two industrialized areas, Leesun Kim, Jin-Woo Jeon, Ji-Young Son, Min-Kyu Park, Chul-Su Kim, wang-Ju Jeon, Tae-Hoon Nam, Kyeongsoon Kim, Byung-Jun Park, Sung-Deuk Choi, Sung-Eun Lee, Environmental Geochemistry and Health (2017) 39(2) 279?291
  • Safety and potential efficacy of gemfibrozil as a supportive treatment for children with late infantile neuronal ceroid lipofuscinosis and other lipid storage disorders, Kyeongsoon Kim, Hynda K. Kleinman, Hahn-Jun Lee and Kalipada Pahan, Orphanet Journal of Rare Diseases (2017) 12:113
  • Antifungal and antiaflatoxigenic effects of a fumigant, ethanedinitrile, on Aspergillus flavus, Hoon Choi, Byung-Ho Lee, Young-sun Moon, Kyeongsoon Kim, Hoi-Seon Lee, Sung-Eun Lee, Applied Biological Chemistry (2017) 60(5) 473-476
  • Platycodon saponins from Platycodi Radix (Platycodon grandiflorum) for the Green Synthesis of Gold and Silver Nanoparticles, Yoonho Choi, Sehyeon Kang, Song-Hyun Cha,Hyun-Seok Kim, Kwangho Song, You Jeong Lee, Nanoscale Research Letters (2018) 13(1), 23-33 
  • Effective Adaptive Dynamic Quadrature Demodulation in Medical Ultrasound Imaging, Heechul Yoon, Kang-won Jeon, Hyuntaek Lee, Kyeongsoon Kim and Changhan Yoon, Journal of Electrical Engineering & Technology (2018) 13(1) 468-475
  • Concurrent application of ethyl formate and 1-methylcyclopropene to control Tetranychus urticae on exported sweet persimmons (Diospyros kaki Thunb. ‘Fuyu’), Byung-Ho LEE, Chung-Gyoo PARK, Jeong-Oh YANG, Kyeongsoon KIM and Sung-Eun LEE, ENTOMOLOGICAL RESEARCH (2018) 48(3), 198-203
  • RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model, Chae Eun Kim, Hynda K. Kleinman, Gabriel Sosne, George W Ousler, Kyeongsoon Kim,Sinwook Kang & Jaewook Yang, Scientific Reports (2018) 8, 10500
  • Antifungal and Antiaflatoxigenic Activities of 1,8-Cineole and t-Cinnamaldehyde on Aspergillus flavus, Hyeong-Mi Kim, Hyunwoo Kwon, Kyeongsoon Kim and Sung-Eun Lee, Applied Sciences-Basel (2018) 8(9), 1655
  • Real-Time Lossless Compression Algorithm for Ultrasound Data Using BL Universal Code, Jung Hoon Kim, Sunmi Yeo, Jong Won Kim, Kyeongsoon Kim, Tai-Kyong Song, Changhan Yoon and Joohon Sung, SENSORS (2018), 18(10), 3314
  • Matrigel uses in cell biology and for the identification of thymosin b4, a mediator of tissue regeneration, Hynda K. Kleinman. Kyeongsoon Kim. Hunhee Kang, Applied Biological Chemistry (2018) 61(6), 703-708
  • OKN-007 Increases temozolomide (TMZ) Sensitivityand Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth, Rheal A. Towner, Nataliya Smith, Debra Saunders, Chase A. Brown, Xue Ca, Jadith Ziegler, Samantha Mallory, Mikhail G. Dozmorov, Patricia Coutinho De Souza, Graham Wiley, Kyeongsoon Kim, Shinwook Kang, Translational Oncology, 12(2), 320-335
  • B-cell translocation gene 2 enhances fbroblast growth factor 21 production by inducing Kruppel like factor 15, Yong Deuk Kim, Seung-Lark Hwang, Hwang-Ju Jeon, Yong Hyun Jeon, Balachandar Nedumaran, Kyeongsoon Kim & Sung-Eun Lee, (2019) 3730


특허

  • FORMULATION COMPRISING THYMOSIN BETA 4 (티모신베타4를함유하는제형), 10-2014-0143585, KR, 2014.10.22
  • COMPOSITION COMPRISING THYMOSIN BETA 4 (티모신베타4를함유하는조성물), 10-2014-0143606, KR, 2014.10.22
  • COMPOSITION AND FORMULATION COMPRISIN, PCT/KR2015/008621, 2015.08.18
  • PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING CORNEAL WOUND COMPRISING THYMOSIN β4 AND CITRIC ACID, 14/844,421, US, 2015.09.04
  • A pharmaceutical composition for treating or preventing corneal wound comprising thymosine β4 and citric acid(티모신 β4 및 시트르산을 유효성분으로 포함하는 각막 손상 예방 또는 치료용 조성물), 10-2016-0103066, KR, 2016.08.12
  • A pharmaceutical composition for treating or preventing corneal wound comprising thymosine β4 and citric acid, PCT/KR2016/008924, 2016.08.12
  • A pharmaceutical composition for treating neurotrophic keratopathy(티모신 β4를 유효성분으로 포함하는 신경영양성각막염 치료용 조성물), 10-2015-0116315, KR, 2015.08.18
  • A pharmaceutical composition for treating neurotrophic keratopathy, PCT/KR2015/013974, 2015.12.18
  • OPHTHALMIC METHODS OF TREATING DRY EYE SYNDROME, 62/363,565, US, 2016.07.18